Revolution Medicines, Inc. RVMD Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s interest coverage?
- Revolution Medicines, Inc. (RVMD) reported interest coverage of -38.1× in Q1 2026.
- What is the long-term trend for Revolution Medicines, Inc.'s interest coverage?
- Over 2 years (2020 to 2025), Revolution Medicines, Inc.'s interest coverage has grown at a -82.3% compound annual growth rate (CAGR), from -1,559.1× to -48.8×.
- What does interest coverage mean?
- How many times the company's operating profit covers its interest bill.
- How do you interpret interest coverage?
- Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
- How does interest coverage compare across companies?
- Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.